Accuvein Inc.

Accuvein Inc., doing business as Accuvein LLC, manufactures and sells infrared vein visualization systems and related medical equipment to federal healthcare agencies exclusively as a prime contractor on a GSA Schedule contract. The company is a for-profit manufacturer based in Medford, New York, competing full-and-open without set-aside designations across most of its federal footprint, though a small subset of orders carries Total Small Business set-aside framing.

Accuvein's federal capability centers on the AV500 vein visualization system and related accessories—infrared imaging devices that project vein maps onto patient skin to assist healthcare professionals in performing vascular access procedures. Representative work includes a $104,788.95 delivery order from the Department of Veterans Affairs Veterans Integrated Service Network 17 for AccuVein monitors (awarded May 2026 under GSA Schedule Medical Equipment and Supplies FSS-65-II-A); a $188,591.91 delivery order from VA VISN 5 for vein finder devices to the DC VA Medical Center (September 2023); and a $37,709.34 delivery order from the NIH Clinical Center for AV500 systems (July 2024). The company has also supplied the Defense Health Agency and the Indian Health Service through the same GSA Schedule vehicle.

Customer concentration is extreme and VA-centric. The top five customer agencies—measured by award count—account for only 35% of awards but include Indian Health Service (16 awards, $198 thousand combined potential value), VA VISN 7 (15 awards, $644 thousand), and Navy Bureau of Medicine and Surgery (15 awards, $180 thousand). When measured by potential dollar value, concentration tightens dramatically: VA VISN 12 alone anchors $13.6 million across eight awards, and VA Headquarters adds $3.4 million across three awards. Together, the top five customers by potential value represent 85% of the entire $21.6 million combined portfolio. The VA system dominates Accuvein's federal revenue.

Accuvein's vehicle position is narrow and stable. All 193 task orders sit on the Medical Equipment and Supplies GSA Schedule (FSS-65-II-A), a multiple-award vehicle with a $5 million ceiling running through August 2030. Three additional task orders place on Indefinite Delivery Contract 36C10G18D0080 (combined potential value $1.7 million). The GSA Schedule is the company's sole leveraged vehicle; delivery orders are placed directly by individual VA VISNs and other healthcare agencies without intermediary IDIQs or BPAs.

Activity has contracted year over year. The source data spans 2009 to 2026, but recent trajectory shows decline: 12 awards in 2022, 10 in 2023, 4 in 2024, 3 in 2025, and 2 in 2026. Combined potential value is $21.6 million against $6.3 million obligated (29% of ceiling). Recompete exposure is minimal: only one award faces completion in the next twenty-four months, with combined potential value of $105 thousand. Primary NAICS concentration sits in Electromedical and Electrotherapeutic Apparatus Manufacturing (178 of 213 awards), with PSC Medical and Surgical Instruments, Equipment, and Supplies dominating (181 awards). Accuvein operates with zero subcontractors; all 213 awards are prime contracts, reflecting a pure-play manufacturing and direct-sale posture with no teaming or sub-engagement footprint in federal work.

AccuVein has a contract with the GSA. AccuVein develops simple solutions to improve vascular access outcomes for patients undergoing IV therapy, venous access procedures, or other treatments. The company has developed the only class 1, real-time, laser-based device that uses near-infrared (NIR) to help clinicians see superficial veins, valves, and bifurcations for better-informed decision making and accurate needle placement. When clinicians use an AccuVein device for pre-insertion assessment, they can rapidly identify optimal vein targets. This not only dramatically increases first attempt success and reduces escalation calls, but it also helps ensure that catheters last for the duration of therapy. With its patented True Center technology, AccuVein is the first and only vein visualization device that is permanently aligned and does not require calibration, allowing clinicians to accurately view the centerline of the vein with each use.